We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current IMTX market cap is 826.94M. The company's latest EPS is EUR -0.9407 and P/E is -8.51.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Revenue | 10.74M | 22.36M | 6.11M | 15.93M | 30.28M |
| Operating Income | -26.43M | -14.31M | -37.3M | -27.71M | -13.47M |
| Net Income | -19.75M | -24.61M | -26.49M | -26.15M | -3.05M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Revenue | 18.83M | 31.56M | 35.09M | 172.86M | 55.14M |
| Operating Income | -33.01M | -69.72M | -86.29M | 29.95M | -101.73M |
| Net Income | -31.57M | -211.28M | -93.34M | 37.51M | -96.99M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Assets | 378.49M | 410.19M | 437.45M | 509.97M | 653.13M |
| Total Liabilities | 178.4M | 191.98M | 189.7M | 284.88M | 252.34M |
| Total Equity | 200.08M | 218.21M | 247.75M | 225.08M | 400.79M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Assets | 134.28M | 254.65M | 174.65M | 407.82M | 509.97M |
| Total Liabilities | 175.11M | 167.26M | 150.58M | 194.66M | 284.88M |
| Total Equity | -40.84M | 87.39M | 24.06M | 213.16M | 225.08M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Operating | -23.72M | -30.32M | -60.85M | 18.23M | -32.61M |
| Investing | -3.72M | -20.56M | -91.13M | -31.39M | -241.82M |
| Financing | -866k | 35.59M | 85.49M | 84.52M | 174.65M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Operating | 68.05M | -85.61M | -81.78M | 100.13M | 18.23M |
| Investing | -2.14M | -15.95M | 7.49M | -209.79M | -31.39M |
| Financing | -1.86M | 207.88M | -2.61M | 123.71M | 84.52M |
| Market Cap | 826.94M |
| Price to Earnings Ratio | -8.51 |
| Price to Sales Ratio | 14.98 |
| Price to Cash Ratio | 3.78 |
| Price to Book Ratio | 3.67 |
| Dividend Yield | - |
| Shares Outstanding | 103.11M |
| Average Volume (1 week) | 447.17k |
| Average Volume (1 Month) | 654.55k |
| 52 Week Change | -11.18% |
| 52 Week High | 13.77 |
| 52 Week Low | 7.46 |
| Spread (Intraday) | 0.03 (0.37%) |
| Company Name | Immatics NV |
| Address |
paul-ehrlich-street 15 tubingen 72076 |
| Website | https://www.immatics.com |
| Industry | health & allied services,nec (8099) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
